International note Retatrutide is also not approved in the UK, EU, Australia, Canada, or any other major market as of June 2026
Patients should discuss with their healthcare provider how retatrutide fits into their overall treatment plan, taking into account their medical history, current medications, and the potential for greater average weight loss compared to other weight loss medications
Behind the scenes, participating manufacturers provide the drugs at a net price of $245 per month
Beard, E
Um where does that development stand and it sounds like uh, you know, maybe I'm wrong, it sounds like Pfizer is going to probably just try to jump directly to the oral route with this uh acquisition or or where where are we at there
Heres a simple breakdown based on studies: Retatrutide: Side effects and safety considerations Retatrutide is still being studied, but clinical trials already give a helpful picture of what side effects people might experience